Form 4: Molina Healthcare Director Dale B. Wolf Reports Acquisition of Common Stock

Director Dale B. Wolf reports the acquisition of 189 shares of Molina Healthcare common stock as part of the company's 2019 Equity Incentive Plan.

Summary

• On January 1, 2025, Dale B. Wolf, a director of Molina Healthcare, Inc., acquired 189 shares of common stock.
• The acquisition was part of the Issuer's 2019 Equity Incentive Plan and is related to Wolf's service as a Director.
• The shares were granted at a price of $291.05, based on the closing price of Molina Healthcare's common stock on December 31, 2024.
• Following the transaction, Wolf directly owns 15,541 shares of Molina Healthcare common stock.
• The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (director stock grant) and doesn't contain any alarming information. The sentiment is neutral to slightly positive as it indicates continued director investment in the company.

Positives

• The equity grant aligns the director's interests with those of the shareholders.
• The director increased their holdings in the company.

Industry Context

Director equity grants are a common practice in publicly traded companies to align the interests of board members with those of shareholders. This grant is part of Molina Healthcare's standard compensation practices for its directors.

Comparison to Industry Standards

• Director compensation packages, including equity grants, vary significantly across the healthcare industry depending on company size, performance, and governance practices.
• Comparing Molina Healthcare's director compensation to peers like UnitedHealth Group, Anthem (now Elevance Health), or Humana would provide a better understanding of whether the equity grant is in line with industry standards.
• Typically, director compensation includes a mix of cash retainers, meeting fees, and equity awards, with the equity component designed to incentivize long-term value creation.

Stakeholder Impact

• The equity grant aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit shareholders.
• The transaction itself has minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates